Clinical outcomes in Black patients with EGFR-mutated NSCLC treated with osimertinib

被引：0
|
作者：
Belani, Neel
Rizwan, Farsha
Hasler, Jill
Bauman, Jessica
Mitchell, Khadijah
Borghaei, Hossein
Bodor, Joseph N.
机构：
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2024年 / 33卷 / 09期
关键词：
D O I：
10.1158/1538-7755.DISP24-A087
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A087
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
    Tsuboi, Masahiro
    Herbst, Roy S.
    John, Thomas
    Kato, Terufumi
    Majem, Margarita
    Grohe, Christian
    Wang, Jie
    Goldman, Jonathan W.
    Lu, Shun
    de Marinis, Filippo
    Shepherd, Frances A.
    Lee, Ki Hyeong
    Le, Nhieu Thi
    Dechaphunkul, Arunee
    Kowalski, Dariusz
    Bonanno, Laura
    Domine, Manuel
    Poole, Lynne
    Bolanos, Ana
    Rukazenkov, Yuri
    Wu, Yi-Long
    TARGETED ONCOLOGY, 2024, 19 (02) : 131 - 134
  • [22] Osimertinib in Stage III EGFR-Mutated NSCLC - Game, Set, Match
    Leighl, Natasha B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (07): : 652 - 654
  • [23] Socioeconomic Disparities and Overall Survival Differences Among Ethnic-Minority Patients with EGFR-Mutated NSCLC Treated with Osimertinib
    Lee, M.
    Miao, E.
    Zhang, C.
    Xue, X.
    Tuckman, S.
    Ohri, N.
    Halmos, B.
    Cheng, H.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S192 - S194
  • [24] Neoadjuvant Osimertinib with/without Chemotherapy versus Chemotherapy in Patients with EGFR-mutated resectable NSCLC: NeoADAURA
    Griesinger, F.
    Tsuboi, M.
    Weder, W.
    Escriu, C.
    Blakely, C.
    He, J.
    Dacic, S.
    Yatabe, Y.
    Zeng, L.
    Walding, A.
    Chaft, J.
    PNEUMOLOGIE, 2021, 75 : S6 - S7
  • [25] Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases
    Mei-Mei Zheng
    Yang-Si Li
    Hai-Yan Tu
    Hao Sun
    Kai Yin
    Ben-Yuan Jiang
    Jin-Ji Yang
    Xu-Chao Zhang
    Qing Zhou
    Chong-Rui Xu
    Zhen Wang
    Hua-Jun Chen
    De-Xiang Zhou
    Yi-Long Wu
    BMC Medicine, 20
  • [26] Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
    Wu, Yi-Long
    John, Thomas
    Grohe, Christian
    Majem, Margarita
    Goldman, Jonathan W.
    Kim, Sang-We
    Kato, Terufumi
    Laktionov, Konstantin
    Vu, Huu Vinh
    Wang, Zhijie
    Lu, Shun
    Lee, Kye Young
    Akewanlop, Charuwan
    Yu, Chong-Jen
    de Marinis, Filippo
    Bonanno, Laura
    Domine, Manuel
    Shepherd, Frances A.
    Zeng, Lingmin
    Atasoy, Ajlan
    Herbst, Roy S.
    Tsuboi, Masahiro
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (03) : 423 - 433
  • [27] Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases
    Zheng, Mei-Mei
    Li, Yang-Si
    Tu, Hai-Yan
    Sun, Hao
    Yin, Kai
    Jiang, Ben-Yuan
    Yang, Jin-Ji
    Zhang, Xu-Chao
    Zhou, Qing
    Xu, Chong-Rui
    Wang, Zhen
    Chen, Hua-Jun
    Zhou, De-Xiang
    Wu, Yi-Long
    BMC MEDICINE, 2022, 20 (01)
  • [28] Association of different EGFR mutations with different outcomes in EGFR-mutated NSCLC patients treated with tyrosine kinase inhibitors.
    Ulivi, Paola
    Petracci, Elisabetta
    Dazzi, Claudio
    Verlicchi, Alberto
    Canale, Matteo
    Chiadini, Elisa
    Capelli, Laura
    Gamboni, Alessandro
    Papi, Maximilian
    Burgio, Marco Angelo
    Mariotti, Marita
    De Luigi, Nicoletta
    Ludovini, Vienna
    Bennati, Chiara
    Chiari, Rita
    Crino, Lucio
    Amadori, Dino
    Delmonte, Angelo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Treatment Strategies and Survival Outcomes of Patients with EGFR-mutated NSCLC and leptomeningeal metastasis
    Fan, Y.
    Wu, H.
    Chen, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S652 - S652
  • [30] Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC
    Gulikers, Judith L.
    Veerman, G. D. Marijn
    Jebbink, Merel
    Kruithof, Paul D.
    Steendam, Christi M. J.
    Boosman, Rene J.
    Mathijssen, Ron H. J.
    Tjan-Heijnen, Vivianne C. G.
    Driessen, Johanna H. M.
    Dursun, Safiye
    Smit, Egbert F.
    Dingemans, Anne -Marie C.
    van Geel, Robin M. J. M.
    Croes, Sander
    Hendriks, Lizza E. L.
    JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (04):
12345